pJEP312-pAAV-CMV-SaCas9-P2A-HAFLAGHA-KASH-pA Citations (2)

Originally described in: The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in vivo and Regulated via Doxycycline and Cre-Recombinase.
Kumar N, Stanford W, de Solis C, Aradhana, Abraham ND, Dao TJ, Thaseen S, Sairavi A, Gonzalez CU, Ploski JE Front Mol Neurosci. 2018 Nov 13;11:413. doi: 10.3389/fnmol.2018.00413. eCollection 2018. PubMed Journal

---

Articles Citing pJEP312-pAAV-CMV-SaCas9-P2A-HAFLAGHA-KASH-pA

Articles
Fibulin-2 is an extracellular matrix inhibitor of oligodendrocytes relevant to multiple sclerosis. Ghorbani S, Li C, Lozinski BM, Moezzi D, D'Mello C, Dong Y, Visser F, Li H, Silva C, Khakpour M, Murray CJ, Tremblay ME, Xue M, Yong VW. J Clin Invest. 2024 May 14;134(13):e176910. doi: 10.1172/JCI176910. PubMed
Therapeutic reduction of neurocan in murine intracerebral hemorrhage lesions promotes oligodendrogenesis and functional recovery. Li H, Ghorbani S, Oladosu O, Zhang P, Visser F, Dunn J, Zhang Y, Ling CC, Yong VW, Xue M. J Neuroinflammation. 2025 Jan 4;22(1):2. doi: 10.1186/s12974-024-03331-0. PubMed

If you have published an article using this material, please email us at to have your article added to this page.